Novartis to acquire Avidity Biosciences for $12 billion | Healthcare 360 Magazine

Basel, Switzerland, Oct. 26—Swiss pharmaceutical company Novartis said Sunday it will acquire the U.S.-based biotechnology firm Avidity Biosciences for about $12 billion in cash, Read For More information

Posted : 27.10.2025 | 0 views

Collection : Flights